Viracta Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $738 | $0 |
Gross Profit | -96 | -110 | 615 | -128 |
EBITDA | -9,493 | -13,766 | -13,437 | -12,475 |
EBIT | -9,589 | -13,876 | -13,560 | -12,603 |
Net Income | -9,830 | -9,141 | -13,765 | -12,600 |
Net Change In Cash | 0 | 0 | 738 | 0 |
Free Cash Flow | -9,827 | -7,849 | -10,027 | -10,484 |
Cash | 13,981 | 12,062 | 12,317 | 12,856 |
Basic Shares | 39,404 | 39,323 | 38,790 | 38,683 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $120 |
Gross Profit | -492 | -210 | -178 | 88 |
EBITDA | -50,201 | -50,379 | 62,680 | -18,769 |
EBIT | -50,693 | -50,589 | 62,502 | -18,801 |
Net Income | -51,058 | -49,774 | -203,062 | -19,199 |
Net Change In Cash | 0 | 0 | 0 | 120 |
Cost of Revenue | -66,781 | 56,465 | 2,149 | |
Free Cash Flow | -40,030 | -35,502 | -23,103 | -16,109 |
Cash | 12,317 | 36,773 | 103,554 | 47,089 |
Basic Shares | 38,624 | 37,790 | 31,870 | 92 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.25 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.35 |
2023-09-30 | -$0.33 |
